Margaret F Bedillion1, Emily B Ansell2, Gwendolyn A Thomas3. 1. Department of Exercise Science, 201 Women's Building, Syracuse University, USA. Electronic address: mfbedill@syr.edu. 2. Department of Psychology, 430 Huntington Hall, Syracuse University, USA; Program in Neuroscience, 362 Life Sciences, Syracuse University, USA. Electronic address: ebansell@syr.edu. 3. Department of Exercise Science, 201 Women's Building, Syracuse University, USA; Program in Neuroscience, 362 Life Sciences, Syracuse University, USA. Electronic address: gwthomas@syr.edu.
Abstract
OBJECTIVES: Breast cancer survivors report significant cognitive impairments post treatment, particularly following chemotherapy. Depression may also occur post treatment and may partially mediate the effects of cancer treatment on cognition. Additionally, physical activity has been shown to mitigate treatment effects on cognition and depression. This study examined the role of depression in mediating the effects of cancer treatment on cognitive function (perceived cognitive impairment, PCI; perceived cognitive ability, PCA) in breast cancer survivors and explored the role of physical activity in moderating these effects. MATERIALS AND METHODS: 317 breast cancer survivors were recruited via Army of Women. Participants were 40-75 years old and had stage 0 (in situ) to IIIc breast cancer and were less than 10 years post treatment. Participants completed a demographic and treatment questionnaire, as well as the International Physical Activity Questionnaire, Functional Assessment of Cancer Therapy-Cognitive Function, and Center for Epidemiologic Studies Depression Scale. RESULTS: Depressive symptoms significantly contributed to cognitive function in all models. Moderate and vigorous levels of physical activity moderated breast cancer treatment effects on depression and cognition. Chemotherapy, tamoxifen, and anastrozole all demonstrated negative effects on cognition. CONCLUSION: The results from this study support the importance of examining mediating factors in the effects of cancer treatment on cognition, particularly depression, following cancer treatment. Effects of treatment on cognition in breast cancer survivors are partially explained by changes in depressive symptoms, although chemotherapy may impact cognition independent of depression. Importantly, physical activity may reduce the risk of depression and cognitive impairment in breast cancer survivors.
OBJECTIVES:Breast cancer survivors report significant cognitive impairments post treatment, particularly following chemotherapy. Depression may also occur post treatment and may partially mediate the effects of cancer treatment on cognition. Additionally, physical activity has been shown to mitigate treatment effects on cognition and depression. This study examined the role of depression in mediating the effects of cancer treatment on cognitive function (perceived cognitive impairment, PCI; perceived cognitive ability, PCA) in breast cancer survivors and explored the role of physical activity in moderating these effects. MATERIALS AND METHODS: 317 breast cancer survivors were recruited via Army of Women. Participants were 40-75 years old and had stage 0 (in situ) to IIIc breast cancer and were less than 10 years post treatment. Participants completed a demographic and treatment questionnaire, as well as the International Physical Activity Questionnaire, Functional Assessment of Cancer Therapy-Cognitive Function, and Center for Epidemiologic Studies Depression Scale. RESULTS:Depressive symptoms significantly contributed to cognitive function in all models. Moderate and vigorous levels of physical activity moderated breast cancer treatment effects on depression and cognition. Chemotherapy, tamoxifen, and anastrozole all demonstrated negative effects on cognition. CONCLUSION: The results from this study support the importance of examining mediating factors in the effects of cancer treatment on cognition, particularly depression, following cancer treatment. Effects of treatment on cognition in breast cancer survivors are partially explained by changes in depressive symptoms, although chemotherapy may impact cognition independent of depression. Importantly, physical activity may reduce the risk of depression and cognitive impairment in breast cancer survivors.
Authors: M Lange; F Joly; J Vardy; T Ahles; M Dubois; L Tron; G Winocur; M B De Ruiter; H Castel Journal: Ann Oncol Date: 2019-12-01 Impact factor: 32.976
Authors: Inger Utne; Bruce A Cooper; Christine Ritchie; Melisa Wong; Laura B Dunn; Borghild Loyland; Ellen Karine Grov; Marilyn J Hammer; Steven M Paul; Jon D Levine; Yvette P Conley; Kord M Kober; Christine Miaskowski Journal: Eur J Oncol Nurs Date: 2020-08-03 Impact factor: 2.398
Authors: Nicole Rodriguez; Jonathan M Fawcett; Joshua A Rash; Renee Lester; Erin Powell; Connor D MacMillan; Sheila N Garland Journal: Cancer Med Date: 2021-01-16 Impact factor: 4.452
Authors: Kevin H McLaughlin; Stuart L Mitchell; Kristin R Archer; Hiral Master; Saam Morshed; Joshua L Gary; Clifford B Jones; Ellen J MacKenzie; Lisa Reider Journal: Arch Phys Med Rehabil Date: 2021-08-21 Impact factor: 4.060
Authors: Alberto Soriano-Maldonado; Álvaro Carrera-Ruiz; David M Díez-Fernández; Alba Esteban-Simón; Mercedes Maldonado-Quesada; Nuria Moreno-Poza; María Del Mar García-Martínez; Celia Alcaraz-García; Rosa Vázquez-Sousa; Herminia Moreno-Martos; Antonio Toro-de-Federico; Nur Hachem-Salas; Eva Artés-Rodríguez; Manuel A Rodríguez-Pérez; Antonio J Casimiro-Andújar Journal: Medicine (Baltimore) Date: 2019-11 Impact factor: 1.817
Authors: David Kiesl; Marina Kuzdas-Sallaberger; David Fuchs; Silvana Brunner; Romana Kommenda; Clemens Tischler; Herwig Hornich; Kaveh Akbari; Jörg Kellermair; Hermann Blessberger; Helmuth Ocenasek; Peter Hofmann; Philipp Zimmer; Milan R Vosko Journal: Front Neurol Date: 2022-03-25 Impact factor: 4.003
Authors: Rebecca A Harrison; Noha Sharafeldin; Jennie L Rexer; Brennan Streck; Melissa Petersen; Ashley M Henneghan; Shelli R Kesler Journal: Oncologist Date: 2021-07-12